Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials.

Kang, S K

Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials. [electronic resource] - Clinical oncology (Royal College of Radiologists (Great Britain)) May 2016 - 334-41 p. digital

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

1433-2981

10.1016/j.clon.2015.12.004 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Axitinib
Benzimidazoles--administration & dosage
Carcinoma, Renal Cell--drug therapy
Humans
Imidazoles--administration & dosage
Indazoles--administration & dosage
Kidney Neoplasms--drug therapy
Niacinamide--administration & dosage
Phenylurea Compounds--administration & dosage
Prognosis
Quinolines--administration & dosage
Quinolones--administration & dosage
Randomized Controlled Trials as Topic
Sorafenib
Survival Rate
Vascular Endothelial Growth Factor A--antagonists & inhibitors